Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Eliquis13.33B27.60%
Opdivo9.3B19.26%
Revlimid5.77B11.95%
Other5.47B11.32%
Orencia3.68B7.62%
Pomalyst/Imnovid3.55B7.34%
Yervoy2.53B5.24%
Reblozyl1.77B3.67%
Other Growth products1.61B3.32%
Sprycel1.29B2.66%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States34.11B70.61%
International13.2B27.33%
Other996M2.06%